Cargando…
Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model
Prostate cancer patients with high WNT5A expression in their tumors have been shown to have more favorable prognosis than those with low WNT5A expression. This suggests that reconstitution of Wnt5a in low WNT5A-expressing tumors might be an attractive therapeutic approach. To explore this idea, we h...
Autores principales: | Canesin, Giacomo, Evans-Axelsson, Susan, Hellsten, Rebecka, Krzyzanowska, Agnieszka, Prasad, Chandra P., Bjartell, Anders, Andersson, Tommy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5590932/ https://www.ncbi.nlm.nih.gov/pubmed/28886116 http://dx.doi.org/10.1371/journal.pone.0184418 |
Ejemplares similares
-
Therapy for BRAFi-Resistant Melanomas: Is WNT5A the Answer?
por: Prasad, Chandra Prakash, et al.
Publicado: (2015) -
WNT5A as a therapeutic target in breast cancer
por: Prasad, Chandra Prakash, et al.
Publicado: (2018) -
Interleukin‐6 drives melanoma cell motility through p38α‐MAPK‐dependent up‐regulation of WNT5A expression
por: Linnskog, Rickard, et al.
Publicado: (2014) -
Elevated Level of Wnt5a Protein in Localized Prostate Cancer Tissue Is Associated with Better Outcome
por: Syed Khaja, Azharuddin Sajid, et al.
Publicado: (2011) -
WNT‐5A triggers Cdc42 activation leading to an ERK1/2 dependent decrease in MMP9 activity and invasive migration of breast cancer cells
por: Prasad, Chandra Prakash, et al.
Publicado: (2013)